NTRK Testing Webinar

3 June 2021

The Genomic Medicine Service and NTRK Tumour Agnostic Testing and Treatment Pathways in Solid Tumours
Virtual educational meeting: Wednesday 16th June 2021: 5.30pm – 6.45pm

The North Thames Genomic Laboratory Hub are delighted to host this educational meeting and welcomes healthcare professional attendees from our regional cancer clinical teams.

Aims: To explore the role of the NHS genomic medicines service in delivering cancer genomic testing via the regional network of GLH’s and to examine the clinical testing and treatment landscape associated with managing patients with NTRK gene-fusions. Click here to register!


5:30pm Welcome and introductions
Dr Angela George, Clinical Director (Cancer), North Thames GLH
5.35pm The role of the Genomic Medicine Service in precision oncology
Dr Angela George, Clinical Director (Cancer), North Thames GLH
5.45pm The NTRK testing and treatment landscape and patient case study: A clinician’s perspective (Bayer sponsored session)
Dr Martin Forster, Associate Professor and Consultant in Medical Oncology UCL Cancer Institute
6.00pm NTRK testing and reporting pathways
Dr Mike Hubank, Scientific Director, North Thames GLH
6.15pm Sample requirements, tumour assessments and optimising tissue pathways
Professor Louise Jones, Pathology Lead, North Thames GLH
6.30pm-6:45pm Q & A: Panel

For more information please contact corinnetrim@nhs.net

This educational event is organised by the North Thames NHS Genomics Laboratory Hub and sponsored by Bayer. The level of sponsorship covers the digital platform the meeting is hosted on, the meeting recording and the guest speaker fee. Bayer has had no influence over the content of the presentations outside of the sponsored guest speaker.